Addressing Mental Health Disparities in Spanish Speaking Latina Breast Cancer Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- Stanford University
- Enrollment
- 31
- Locations
- 1
- Primary Endpoint
- Difference in Feasibility
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The purpose of the study is to:Translate a mindfulness program into Spanish for Latina patients with breast cancer.Train a community health worker to facilitate the mindfulness program. Determine if this program is culturally acceptable and feasible, and Obtain pilot data on the program's effectiveness in reducing anxiety and depression
Detailed Description
Primary aims of this study are to: 1) translate a behavioral health intervention into Spanish, 2) deliver it to a population of Spanish speaking Latina breast cancer patients, and 3) determine acceptability and feasibility. Secondary aims are to gather preliminary data on anxiety, depression and sleep quality pre and post intervention.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Self reported diagnosis of invasive breast cancer who has currently or within last 12 months been in active treatment (surgery, chemotherapy, or radiation) or on endocrine therapy
- •Self-identified anxiety (persistent worry or nervousness), depression (feeling sad, little interest or pleasure in doing things or hopeless), or sleep disturbance.
- •Breast cancer related treatment (surgery, radiation, chemotherapy) or endocrine therapy within the last 12 months
- •Self identifies as Spanish speaking
- •Self identifies as Latinx / Latina / Latino
- •Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria
- •Non-Spanish speaking
- •other diagnosis besides invasive breast cancer (ie Ductal carcinoma in situ (DCIS), fibroadenoma, abnormal mammogram but not yet with final diagnosis, non-breast cancer patients)
- •comorbid bipolar affective disorder or psychotic disorder (as self-identified by patient after asking "do you have any other psychiatric conditions")
- •inability to physically or psychologically attend group sessions, and by discretion of the study coordinator.
- •Patients currently participation in stress reduction or mindfulness groups/interventions will be excluded from participation
- •Cancer "survivors" if not in active or endocrine treatment
Outcomes
Primary Outcomes
Difference in Feasibility
Time Frame: Through study completion, an average of 1 year
The Feasibility and Satisfaction scale was developed for this study and is a 5 point Likert scored scale that will be administered at at time of completion of intervention or at time of withdraw (if participant withdraws prior to completion of intervention.) Five questions are scored from "strongly disagree" (score 0), "disagree" (score 1), "neutral" (score 2), "agree" (score 3), and "strongly agree" (score 4). Scores range from 0 to 20 with higher scores representing greater levels of feasibility. Differences in Feasibility will be evaluated and reported. There is also 1 open-ended question "What is the optimal number of visits" with continuous numeric score (participants able to write in number of preferred visits) with higher score representing desire for greater number of visits. The scale takes approximately 5-10 minutes to complete
Acceptability change across session
Time Frame: End of each week for 6 weeks
The Acceptability scale was developed for this study and is a 5 point Likert scored scale that will be administered after end of each weeks for 6 weeks. There are two questions with scores ranging from "strongly disagree" (score 0), "disagree" (score 1), "neutral" (score 2), "agree" (score 3), and "strongly agree" (score 4). Scores range from 0 to 8 with the higher scores representing greater levels of acceptability. It has 2 additional open ended questions: "What changes did you make in your daily routine as a result of this intervention, if none, why" and "Were there any barriers to making changes you listed on your action plan, if so what were they? The scale takes approximately 5 minutes to complete. Acceptability change will be measured after each session (week 1-6). The mean score with standard deviation for each 6 sessions and acceptability will be reported.
Secondary Outcomes
- Differences in PROMIS-SD between time points(Three time points (week 1 and 6 of intervention, and 3 months post intervention.))
- Differences in Generalized Anxiety Disorder-7 (GAD7) between time points.(Three time points (week 1 and 6 of intervention, and 3 months post intervention.))
- Differences in Center for Epidemiological Studies-Depression (CES-D) between time points.(Three time points (week 1 and 6 of intervention, and 3 months post intervention.))